16 Locations Serving Across 14 Counties
New Journeys Teams Across Washington State and Counties Served.
The New Journeys program is offered at 16 locations serving individuals across 14 counties.
| Site | Counties Served |
|---|---|
| Cascade Community Healthcare | Cowlitz & Lewis |
| Catholic Charities Serving Central Washington | Chelan & Douglas |
| Clarvida | Grant |
| Clarvida | Pierce |
| Comprehensive Healthcare | Franklin |
| Comprehensive Healthcare | Yakima |
| Frontier Behavioral Health (2 Programs) | Spokane |
| Lifeline Connections | Whatcom |
| Lucid Living | Pierce |
| Peninsula Behavioral Health | Clallam |
| SeaMar | Snohomish |
| SeaMar (formerly Community Services Northwest) | Clark |
| Seattle Children’s Psychosis Program | King |
| STEP/Harborview | King |
| Valley Cities | King |
The following counties do not have coverage:
- Adams
- Asotin
- Benton
- Columbia
- Cowlitz
- Ferry
- Garfield
- Grays Harbor
- Island
- Jefferson
- Kittitas
- Klickitat
- Lewis
- Lincoln
- Mason
- Okanogan
- Pacific
- Pend Oreille
- San Juan
- Skagit
- Skamania
- Stevens
- Thurston
- Wahkiakum
- Walla Walla
- Whitman
New Journeys Measurement Delivery and Evaluation Team
New Journeys is a collaboration between Washington State University Elson S. Floyd College of Medicine, the University of Washington SPIRIT Center, and the Washington State Health Care Authority. Teams at each institution partner with providers across the state to support the implementation and evaluation of the model.
At the WSU College of Medicine, the New Journeys Measurement Delivery and Evaluation Team supports measurement-based care at each clinical outpatient site by providing training and technical assistance to providers and conducting an annual evaluation of the New Journeys Network.
The team is comprised of faculty and training staff from the APPROACHES (Addressing Pathways to Provide & Achieve Equitable Services & Supports) to Community Mental Health Co-lab, housed at the College of Medicine.
Snapshot of New Journeys Outcomes and Impact
The New Journeys model aims to improve outcomes and support recovery for individuals in the early stages of psychosis. The New Journeys Network is evaluated for impact through annual reviews and reporting. View the highlights on the network.
Enrollment
Since Program Launch
Since 2015, the New Journeys Network has received 2,187 referrals, 1,317 individuals have been eligible, and 1,105 individuals enrolled and received services from New Journeys.
16 Days From Referral to Intake
As of June 30, 2025, 185 clients were actively receiving services, 305 (28%) clients had disengaged from services, and 326 (30%) clients had graduated/completed New Journeys in approximately 24 months. In addition, we saw more individuals graduate (49) from network than last year (37 individuals graduated in 2024.)
Fiscal Year 2025
In 2025 alone, the New Journeys network received 419 new referrals, an increase in the number of referrals received in 2024 (n=345) and 2023 (n=298). Of those referrals, 172 individuals enrolled and received services.
The Total Individuals Serves by New Journeys Teams since Program Start.
The New Journeys program has increased enrollment across years. In 2025, the program supported 353 individuals.
| Fiscal Year | Count of Individuals Served |
|---|---|
| 2015 | 4 |
| 2016 | 24 |
| 2017 | 52 |
| 2018 | 103 |
| 2019 | 161 |
| 2020 | 218 |
| 2021 | 285 |
| 2022 | 331 |
| 2023 | 304 |
| 2024 | 297 |
| 2025 | 353 |
Demographics
Among individuals who received services (n=1,105), the majority identified as male (64%) and the average age at intake was 24 years (SD=4.81). Approximately 49% of individuals identified as non-White, 31% identified as Hispanic/Latinx, and 20% identified as LGBTQ+. Most individuals were enrolled in public insurance (79%).
The percentage distribution of enrolled individuals across gender categories.
The majority of enrolled individuals identify as male or female. Some enrolled individuals also identified as non-binary, transgender, other, and unsure/unknown.
- Male: 64.4%
- Female: 30.2%
- Non-binary: 2.5%
- Transgender: 1.4%
- Other: 0.8%
- Unsure/Unknown: 0.7%
The percentage distribution of enrolled individuals across race and ethnicity categories.
The majority of enrolled individuals identify as White/Caucasian, with Other being the second most common category.
- White/Caucasian (non-Hispanic): 51.4%
- Other: 21.4%
- Black/African American: 9.8%
- Multi-Racial: 7.2%
- Alaska Native/American Indian: 4.6%
- Asian: 3.0%
- Pacific Islander: 1.8%
- Prefer Not to Say: 0.8%
The percentage distribution of enrolled individuals across types of housing categories.
The majority of enrolled individuals have stable housing, with Temporary and Institution housing being the second and third most common categories.
- Stable: 86.1%
- Temporary: 5.2%
- Institution: 4.6%
- Unstable: 2.5%
- Homeless: 1.6%
Mental Health History
Approximately 93 % of individuals eligible for New Journeys had a primary diagnosis of non-affective psychosis primary diagnosis.
The average duration of untreated psychosis was approximately 6 months (187 days). 55% of the individuals who received services from New Journeys reported moderate to severe symptoms of depression, 46% reported moderated to severe anxiety, and 34% indicated having thoughts of suicide or self-harm in the past 2 weeks prior to intake.
Approximately 80% of individuals reported lifetime substance use and 52% of individuals reported some form of substance use in the month prior to intake. The most reported recent substance use (30 days prior to intake) was cannabis (73%) and alcohol (55%), followed by sedatives (8%) and stimulants and painkillers (6%).
The percentage of enrolled individuals by primary diagnosis prior to New Journeys eligibility.
Nearly 40% of enrolled individuals were first diagnosed with an unspecified psychosis or psychotic disorder. Approximately 23% of individuals have a primary diagnosis of schizophrenia.
- Psychosis (not otherwise specified)/ Other Specified Psychotic Disorder: 39.1%
- Schizophrenia: 23.2%
- Schizoaffective: 15.8%
- Schizophreniform: 10.1%
- Brief Psychotic Disorder: 3.5%
- Other: 3.4%
- Bipolar Disorder with Psychotic Features: 2.8%
- Major Depression with Psychotic Features: 1.2%
- Delusional Disorder: 0.8%
Mental Health Outcomes
Psychosis Symptoms
Over the course of 24 months, individuals enrolled in New Journeys reported significantly lower symptoms of depression and suicidal ideation (assessed using the PHQ-9), anxiety (assessed using the GAD-7), and psychotic experiences (assessed using the CAPE-P15).
Average severity of depression symptoms across enrollment duration.
Overall severity of depression symptoms was reduced across enrollment in the New Journeys program.
| Enrollment Duration | Symptom Severity: Depression (PHQ-9) |
|---|---|
| INTAKE | 16.25 |
| 4 weeks | 11.47 |
| 8 weeks | 10.26 |
| 12 weeks | 10.80 |
| 16 weeks | 9.07 |
| 20 weeks | 9.07 |
| 24 weeks | 8.96 |
| 28 weeks | 8.42 |
| 32 weeks | 8.03 |
| 36 weeks | 8.43 |
| 40 weeks | 8.31 |
| 44 weeks | 7.77 |
| 48 weeks | 8.19 |
| 52 weeks (1 year) | 7.59 |
| 56 weeks | 8.63 |
| 60 weeks | 6.79 |
| 64 weeks | 6.70 |
| 68 weeks | 7.30 |
| 72 weeks | 7.37 |
| 76 weeks | 6.82 |
| 80 weeks | 7.17 |
| 84 weeks | 6.48 |
| 88 weeks | 6.02 |
| 92 weeks | 5.88 |
| 96 weeks | 5.56 |
| 100 weeks | 6.35 |
| 104 weeks (2 years) | 5.09 |
Average severity of anxiety symptoms across enrollment duration.
Overall severity of anxiety symptoms was reduced across enrollment in the New Journeys program.
| Enrollment Duration | Symptom Severity: Anxiety (GAD-7) |
|---|---|
| INTAKE | 15.25 |
| 4 weeks | 10.60 |
| 8 weeks | 9.49 |
| 12 weeks | 8.91 |
| 16 weeks | 7.81 |
| 20 weeks | 7.31 |
| 24 weeks | 8.25 |
| 28 weeks | 7.74 |
| 32 weeks | 7.60 |
| 36 weeks | 6.81 |
| 40 weeks | 7.61 |
| 44 weeks | 6.35 |
| 48 weeks | 6.98 |
| 52 weeks (1 year) | 6.22 |
| 56 weeks | 6.84 |
| 60 weeks | 5.26 |
| 64 weeks | 5.84 |
| 68 weeks | 6.54 |
| 72 weeks | 7.97 |
| 76 weeks | 6.40 |
| 80 weeks | 7.54 |
| 84 weeks | 7.23 |
| 88 weeks | 5.10 |
| 92 weeks | 6.33 |
| 96 weeks | 5.39 |
| 100 weeks | 7.08 |
| 104 weeks (2 years) | 6.59 |
Average severity of psychosis symptoms across enrollment duration.
Overall severity of psychosis symptoms was reduced across enrollment in the New Journeys program.
| Enrollment Duration | Symptom Severity: Psychosis (CRDPSS) |
|---|---|
| INTAKE | 7.65 |
| 4 weeks | 6.38 |
| 8 weeks | 5.50 |
| 12 weeks | 5.35 |
| 16 weeks | 5.19 |
| 20 weeks | 4.91 |
| 24 weeks | 4.98 |
| 28 weeks | 4.94 |
| 32 weeks | 4.92 |
| 36 weeks | 5.06 |
| 40 weeks | 4.71 |
| 44 weeks | 4.71 |
| 48 weeks | 4.76 |
| 52 weeks (1 year) | 4.85 |
| 56 weeks | 4.69 |
| 60 weeks | 4.55 |
| 64 weeks | 4.36 |
| 68 weeks | 4.57 |
| 72 weeks | 4.31 |
| 76 weeks | 4.52 |
| 80 weeks | 4.64 |
| 84 weeks | 4.44 |
| 88 weeks | 3.78 |
| 92 weeks | 4.05 |
| 96 weeks | 4.40 |
| 100 weeks | 4.84 |
| 104 weeks (2 years) | 4.54 |
Functional Outcomes
Education and Employment
There was a significant increase in school enrollment from 29% at intake to 46% post-intake. Attendance of at least part-time work significantly increased from 26% at intake to 41% post-intake.
The percentage of individuals in school or employed pre- and post-intake.
28.9% of individuals were enrolled in school before the program and 46.3% were enrolled in school after intake. Enrollment in school increased by 18.4%. 25.5% of individuals were employed before the program and 41.2% were employed after intake. Employment increased by 15.7%.
Service Utilization
Of the 1,105 individuals who enrolled in New Journeys, 899 (82%) attended at least one appointment. 71,572 appointments have been scheduled with individuals and their family/support persons since the start of the New Journeys program. Of the number of scheduled services, roughly 77% are attended.
Acknowledgements
This project would not be possible without the support of our partners at the Washington Health Care Authority.
This project was supported by Grant Number B09SM089651 from the Substance Abuse and Mental Health Services Administration (SAMHSA). Its contents are solely the responsibility of the authors and not necessarily represent the official views of the SAMHSA.